Court Report - August 26, 2012

more+
less-

[author: Sherri Oslick]

Gavel About Court Report:  Each week we will report briefly on recently filed biotech and pharma cases.

Merck Sharp & Dohme Corp. v. Watson Laboratories, Inc.
3:12-cv-05228; filed August 20, 2012 in the District Court of New Jersey

Infringement of U.S. Patent Nos. 5,571,817 ("Methods of Treating Androgenic Alopecia with Finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]," issued November 5, 1996), 5,547,957 ("Method of Treating Androgenic Alopecia with 5-α Reductase Inhibitors," issued August 20, 1996), and 5,886,184 ("Finasteride Processes," issued March 23, 1999) following a Paragraph IV certification as part of Watson's filing of an ANDA to manufacture a generic version of Merck's Propecia® (finasteride, used to treat androgenic alopecia).  View the complaint here.  [NB: Merck voluntarily dismissed the case without prejudice 3 days after filing.]

Santarus, Inc. et al. v. Dr. Reddy's Laboratories Inc. et al.
3:12-cv-05202; filed August 15, 2012 in the District Court of New Jersey

• Plaintiffs:  Santarus, Inc.; The Curators of The University of Missouri
• Defendants:  Dr. Reddy's Laboratories Inc.; Dr. Reddy's Laboratories, Ltd.

Infringement of U.S. Patent Nos. 6,699,885 ("Substituted Benzimidazole Dosage Forms and Methods of Using Same," issued March 2, 2004), 6,489,346 (same title, issued December 3, 2002), 6,645,988 (same title, issue November 11, 2003), and 7,399,772 (same title, issued July 15, 2008) following a Paragraph IV certification as part of Dr. Reddy's filing of an ANDA to manufacture a generic version of Santarus' Zegerid® (omeprazole/sodium bicarbonate, used to treat heartburn and other symptoms associated with gastroesophageal reflux disease).  View the complaint here.

 


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McDonnell Boehnen Hulbert & Berghoff LLP | Attorney Advertising

Written by:

more+
less-

McDonnell Boehnen Hulbert & Berghoff LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×
Loading...
×
×